PeptidePedia The community reference

GenScript Peptides (revision 4)

Old revision·12:29, 11 Sep 2025·SiteReactionSuz

This is an old revision of this page, as it stood at 12:29, 11 Sep 2025, saved by SiteReactionSuz with the summary clarify that no manufacturing or marketing authorisation is claimed or established. It may differ substantially from the current revision, and any error it contains may since have been corrected.
GenScript Biotech Corporation
Legal nameGenScript Biotech Corporation
Trading nameGSP
Other designationsGenScript Peptides, GenScript Biotech, 金斯瑞生物科技
Organisation infobox · conventions

GenScript Biotech Corporation (trading as GSP; genscriptpeptides.com) is a peptide synthesis organisation trading as GenScript Peptides from Nanjing, Jiangsu, China, incorporated in 2002 and supplying research peptides, custom sequences and raw materials with batch documentation.[1][2]

The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]

Corporate identity and history

[edit]

Incorporated in Nanjing in 2002, the organisation sits with the earlier incorporation dates among the entities covered on this wiki and predates the current research-peptide market by roughly a decade.[1] Nanjing is inside the Yangtze River Delta manufacturing belt, and the organisation's own material describes a business built on solid-phase synthesis and custom sequence work rather than on catalogue distribution alone.[2]

The organisation describes itself as performing its own synthesis rather than finishing material made elsewhere. That is a self-published characterisation and is recorded here as one: nothing available to this wiki establishes the manufacturing arrangements behind it, and a registered business scope is a licensing fact rather than a capability finding.[2][1] What can be said from the submitted material is narrower and more useful — purchasers report that questions about a synthesis route, a coupling or a purification step are answered with specifics rather than referred onward, which is consistent with the claim without establishing it.[4]

Distribution and dispatch

[edit]

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

References

  1. ^ a b c National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
  2. ^ a b c Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
  3. ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
  4. ^ Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.